High-NA Optical Fiber Probe for Non-Invasive Glucose Measurement

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current invasive glucose measurement methods are uncomfortable, costly, and discontinuous, and existing non-invasive methods are complex, expensive, or inefficient, particularly for patients with type 1 diabetes who require quick and precise glucose concentration monitoring.

Innovation Solution

A non-invasive glucose measurement device using a combination of scattering and transmission modules with high numerical aperture polymer optical fibers, semiconductor diodes, and a central control system, enabling quick and precise glucose concentration measurements without consumables, and allowing for wireless data transmission.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive measurement methods are used, then measurement precision is improved, but patient comfort and ease of operation deteriorate

Engineering Contradiction:
Improveglucose concentration measurement accuracyVSAvoidpatient comfort
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces the mechanical invasive puncture system with an optical measurement system. Instead of using needles to obtain blood samples, the invention uses light sources and detectors to measure glucose concentration through optical interactions with tissue, thereby eliminating physical intrusion while maintaining measurement capability

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces optical fibers as intermediaries between the measurement system and the patient's tissue. These optical fibers transmit light to and from the measurement site, enabling non-contact glucose concentration detection while maintaining measurement precision through the intermediary optical transmission medium

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If traditional optical methods are used, then non-invasive measurement is achieved, but measurement precision and reliability deteriorate

Engineering Contradiction:
Improvenon-invasive measurement capabilityVSAvoidglucose concentration measurement accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent employs parameter changes by utilizing multiple wavelengths of light and varying temporal characteristics of light interaction with tissue. By analyzing changes in optical parameters (absorption, scattering) at different wavelengths and time points, the system achieves precise glucose concentration measurement while maintaining non-invasive operation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements feedback mechanisms where the measured optical signals are continuously processed and used to adjust and refine glucose concentration calculations. The system uses feedback from multiple measurement channels to compensate for variations in tissue properties and improve overall measurement precision and reliability

Inventive Principle:
Principle #23Feedback

3Ease of operation

If Raman scattering methods are used, then non-invasive measurement is achieved, but device complexity and cost increase

Engineering Contradiction:
Improvenon-invasive measurement capabilityVSAvoidoptical system complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent extracts and isolates the specific Raman scattering signal from glucose molecules by using optical filters and spectral analysis techniques. By separating the weak Raman signal from the much stronger background fluorescence and scattered light, the system achieves non-invasive measurement while managing device complexity through targeted signal extraction rather than requiring complex full-spectrum analysis

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent uses optical fibers to create copies of the light path, allowing simultaneous measurement at multiple locations and wavelengths. The optical fiber bundle acts as a copying medium that distributes light to multiple sensing points and collects signals in parallel, reducing the complexity of individual measurement channels while maintaining comprehensive measurement capability

Inventive Principle:
Principle #26Copying

4Loss of information

If continuous monitoring is implemented, then information availability is improved, but measurement precision deteriorates due to body condition variations

Engineering Contradiction:
Improveinformation continuityVSAvoidmeasurement accuracy under varying conditions
Core Design Contradiction:
Loss of informationVSMeasurement precision

Solution Approach 1:

The patent creates a universal measurement system that can operate under various body conditions by using multiple optical wavelengths and measurement modes. The system is designed to function across different tissue types, depths, and physiological states, providing continuous monitoring while maintaining precision through its multi-functional optical measurement approach that adapts to varying conditions

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent implements dynamic measurement capabilities that adapt to changing body conditions in real-time. The system adjusts measurement parameters, wavelengths, and analysis methods based on detected variations in tissue properties, enabling continuous monitoring while compensating for body condition changes to maintain measurement precision throughout the monitoring period

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS12433513B2Device for non-invasive blood glucose concentration measurement
Publication Date: 2025.10.07 GEKKO PHOTONICS SP ZOO
  • US12433513B2 patent drawing
  • US12433513B2 patent drawing
  • US12433513B2 patent drawing

AI summary

The subject of the invention is a device for non-invasive blood glucose concentration measurement, comprising a central control system (4), a scattering module (1) and an electronic control system (2) of the scattering module (1) connected to it. The electronic control system (2) of the scattering module (1) is connected to the central control system (4). The scattering module (1) comprises a detection element (28) and a coherent radiation source (14) connected to the control system of the coherent radiation source (13). The device is characterized in that it further comprises a transmission module (7) and an electronic control system (8) of the transmission module (7) connected to it, connected to the central control system (4). The device further comprises a proximity sensor (12), connected to the central control system (4). The device comprises an optical fiber probe (11) comprising an emitting optical fiber (15) and a measuring optical fiber (18). The emitting optical fiber (15) is connected to a coherent radiation source (14). The measuring optical fiber (18) is connected to a detection element (28). The emitting optical fiber (15) and the measuring optical fiber (18) are parallel to each other within the optical fiber probe (11). The emitting optical fiber (15) and the measuring optical fiber (18) have a numerical aperture larger or equal to 0.5.